about
Challenges in HIV Vaccine Research for Treatment and Prevention.Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA EndoribonucleaseGene therapy for HIV infection.Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs.Development of Lentiviral Vectors Simultaneously Expressing Multiple siRNAs Against CCR5, vif and tat/rev Genes for an HIV-1 Gene Therapy ApproachNew Approach for Inhibition of HIV Entry: Modifying CD4 Binding Sites by Thiolated Pyrimidine Derivatives.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene therapy targeting HIV entry.
@en
Gene therapy targeting HIV entry.
@nl
type
label
Gene therapy targeting HIV entry.
@en
Gene therapy targeting HIV entry.
@nl
prefLabel
Gene therapy targeting HIV entry.
@en
Gene therapy targeting HIV entry.
@nl
P2860
P921
P356
P1433
P1476
Gene therapy targeting HIV entry.
@en
P2093
Chuka Didigu
Robert Doms
P2860
P304
P356
10.3390/V6031395
P5008
P577
2014-03-21T00:00:00Z